Overview

Remimazolam and Emergence Delirium in Pediatrics

Status:
RECRUITING
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
Emergence delirium is a common complication in pediatrics undergoing neurosurgery. Previous study showed that a single bolus of remimazolam was associated with lower incidence of postoperative agitation. Present study was designed to investigate if remimazolam supplemented to sevoflurane anesthesia could decrease the risk of emergence delirium in pediatrics undergoing neurosurgery.
Phase:
PHASE4
Details
Lead Sponsor:
Peking University First Hospital
Treatments:
remimazolam
Saline Solution